- Home
- DYN vs QLYS Comparison
DYN vs QLYS Comparison
Compare DYN & QLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DYN | QLYS |
|---|---|---|
| Founded | 1984 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.4B |
| IPO Year | 2020 | 2012 |
Fundamental Metrics
Financial Performance| Metric | DYN | QLYS |
|---|---|---|
| Price | $17.10 | $87.94 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 12 |
| Target Price | $37.00 | ★ $136.00 |
| AVG Volume (30 Days) | ★ 2.4M | 516.9K |
| Earning Date | 03-02-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.99 |
| EPS | N/A | ★ 5.44 |
| Revenue | N/A | ★ $321,607,000.00 |
| Revenue This Year | N/A | $9.96 |
| Revenue Next Year | N/A | $7.15 |
| P/E Ratio | ★ N/A | $15.75 |
| Revenue Growth | N/A | ★ 15.32 |
| 52 Week Low | $7.01 | $82.06 |
| 52 Week High | $25.00 | $155.47 |
Technical Indicators
Market Signals| Indicator | DYN | QLYS |
|---|---|---|
| Relative Strength Index (RSI) | 47.54 | 33.65 |
| Support Level | $16.34 | $85.14 |
| Resistance Level | $19.77 | $102.25 |
| Average True Range (ATR) | 1.14 | 4.35 |
| MACD | -0.07 | -0.09 |
| Stochastic Oscillator | 6.41 | 26.91 |
Price Performance
Historical ComparisonAbout DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About QLYS Qualys Inc.
Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.